Sponsor

Zhejiang Chinese Medical University

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Zhejiang Chinese Medical University appears in 9 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials9
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

9 shown
Early Warning of Diabetic Peripheral Neuropathy by Using Infrared Thermography and the Effectiveness of Electroacupuncture in Its PreventionNCT06074913 · lead sponsor · 2023-07-07
UNKNOWN
Effects of Electroacupuncture With Different Frequencies for Major Depressive DisorderNCT05144880 · lead sponsor · 2021-11-01
UNKNOWN
Assessing the Impact of Electroacupuncture on Facial Thermal Characteristics of Major Depressive Disorder Patients Based on Infrared Thermal Imaging TechnologyNCT05024149 · lead sponsor · 2021-07-01
UNKNOWN
The Microcirculatory Characteristics of the Heart and Lung Meridians: A Study of COPD Patients and Healthy AdultsNCT04242030 · lead sponsor · 2020-02-01
UNKNOWN
A Study on the Microcirculatory Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With COPDNCT04045418 · lead sponsor · 2020-02-01
UNKNOWN
A Study on the Heat Transport Characteristics of Meridian Phenomenon for the Heart and Lung Meridians Based on Patients With Stable Angina PectorisNCT04046640 · lead sponsor · 2020-02-01
UNKNOWN
Difference in the Metabolic Characteristics of COPD Patients and Healthy AdultsNCT04046666 · lead sponsor · 2020-01-03
UNKNOWN
The Difference in Heat Transport Characteristics of the Heart and Lung MeridiansNCT04046588 · lead sponsor · 2019-10-01
UNKNOWN
A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)NCT02597868 · collaborator · 2013-01-01
UNKNOWN

Drugs studied in this sponsor's trials

1 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Zhejiang Chinese Medical University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Sponsor roles

lead sponsor8
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.